Background: Drug-resistant Providencia rettgeri producing metallo-β-lactamase and 16S rRNA methylase has been reported in several countries. We analyzed P. rettgeri clinical isolates with resistance to carbapenems and aminoglycosides in a hospital in Nepal. Methods: Five clinical isolates of multidrug-resistant P. rettgeri were obtained in a hospital in Nepal. Antimicrobial susceptibilities were determined using the microdilution method and entire genomes were sequenced to determine drug-resistant genes. Epidemiological analysis was performed by pulsed-field gel electrophoresis.
Since then, NDM-1-producing Enterobacteriaceae have been isolated in various parts of the world [9, 10] .
Exogenously acquired 16S rRNA methylase genes responsible for very high levels of resistance to various aminoglycosides are widely distributed among Enterobacteriaceae and glucose-nonfermentative microbes [11] . Gram-negative pathogens producing 16S rRNA methylase ArmA have been isolated in various countries [11] .
Although co-production of several resistance determinants is not rare in Enterobacteriaceae [12] [13] [14] [15] [16] , it is less common in P. rettgeri [5] . We describe here P. rettgeri clinical isolates from Nepal that produce carbapenemase (NDM-1 or OXA-72) and 16S rRNA methylase (ArmA). 
Methods

Bacterial strains
Five P. rettgeri clinical isolates were obtained from May to July 2012 from 5 patients at Tribhuvan University Teaching Hospital in Kathmandu, Nepal. Three isolates were from sputum and 2 from pus at surgical sites. Samples were obtained as part of standard patient care. Phenotypical identification [17] was confirmed by API 32GN (BioMérieux, Mercy l'Etoile, France) and 16S rRNA sequencing (1,497 bp) [18, 19] .
Antimicrobial susceptibilities
MICs were determined using the microdilution method, according to the guidelines of the Clinical Laboratory Standards Institute (CLSI) [20] . Breakpoints to antibiotics were determined. The modified Hodge test, the meropenem-sodium mercaptoacetic acid double-disk synergy test (Eiken Chemical, Tokyo, Japan) and E-test (imipenem/ EDTA) (AB Biodisk, Solna, Sweden) were performed.
Entire genome sequencing
The entire genomes of these isolates were extracted and sequenced by MiSeq (Illumina, San Diego, CA). CLC genomics workbench version 5.5 (CLC bio, Tokyo, Japan) was used for de novo assembly of reads and to search for 923 drug-resistance genes, including genes encoding β-lactamases, 16S rRNA methylases and aminoglycoside-acethyl/adenylyltransferases; point mutations in the gyrA, parC and pmrCAB operons; and point mutations in the fos genes, including fosA, fosA2, fosA3, fosC and fosC2.
Pulsed-field gel electrophoresis (PFGE) and southern hybridization PFGE analysis was performed as described [3] . An 813 bp probe for bla NDM-1 was synthesized by PCR amplification using the primers 5′-atggaattgcccaatattatgcac-3′ (forward) and 5′-tcagcgcagcttgtcggccatgcggg-3′ (reverse), and a 780 bp probe for bla OXA-72 was synthesized using the primers 5′-agtttctctcagtgcatgttcatctat-3′ (forward) and 5′-agaaccagacattccttctttcatttc-3′ (reverse). Southern hybridization to detect bla NDM-1 and bla OXA-72 was performed using these probes, which were detected using DIG High Prime DNA labeling and detection starter kit II (Roche Diagnostics, Mannheim, Germany).
Nucleotide sequence accession numbers
The nucleotide sequences surrounding bla NDM-1 and bla OXA-72 have been deposited in GenBank with the accession number AB828598 and AB857844, respectively.
Ethical approval
The study protocol was reviewed and approved by the Institutional Review Board of the Institute of Medicine, 
Results
Antimicrobial susceptibilities
Four of the 5 isolates were resistant to carbapenems (doripenem, imipenem and meropenem) and piperacillin/tazobactam, whereas the fifth was susceptible to piperacillin/tazobactam, doripenem and meropenem and showed intermediate resistance to imipenem ( Table 1 ). All 5 isolates were highly resistant to cephalosporins (ceftazidime and cefepime), aztreonam, aminoglycosides (arbekacin, amikacin and gentamicin), ciprofloxacin, colistin and fosfomycin, and all 5 showed intermediate resistance to tigecycline. The four isolates resistant to carbapenems were negative with the modified Hodge test, but three of the four isolates were positive with the meropenem-sodium mercaptoacetic acid double-disk synergy test and E-test/EDTA.
Drug-resistant genes
All 5 isolates tested had several genes associated with β-lactam and aminoglycoside-resistance (Table 1) . These isolates had bla VEB-1 , bla OXA-10 , bla TEM-1 , bla ADC-67 (ampC), armA and aadA1; 3 had bla NDM-1 ; and 1 had bla OXA-72 . None of these isolates had any other βlactamase encoding genes, including the class A genes bla SHVs and bla CTX-Ms ; the class B genes bla AIM , bla DIM , bla FIM , bla GIM , bla IMPs , bla INDs , bla KHM , bla SIM , bla SMB , bla SPM , bla TMBs , and bla VIMs ; or the class D gene bla OXAs except for bla OXA-10 and bla OXA-72 . None had other genes encoding 16S rRNA methylases or aminoglycoside acetyl/adenylyltransferases. All 5 isolates had point mutations in the quinolone-resistance-determining regions of gyrA and parC, with amino acid substitutions of S83I and D87E in GyrA and S80I in ParC, but none had any mutations in the pmrCAB operon and fos genes. All sequences of the drug-resistant genes tested were identical to those registered in GenBank. 
PFGE and southern hybridyzation
Of the 5 P. rettgeri isolates, 4 had identical PFGE patterns and the fifth showed 95.7% similarity (Figure 1 ). Three of these isolates had a plasmid harboring bla NDM-1 and one had a plasmid harboring bla OXA-72 , with plasmid sizes ranging from 9.42 to 23.1 kbp (data not shown).
Genomic structures surrounding bla NDM-1 and bla OXA-72
The genetic environments surrounding bla NDM-1 (Accession no. AB828598) was bla NDM-1 -ble MBL -trpF-dsbC-cutA1. All 3 isolates harboring bla NDM-1 (IOMTU1, 91 and 99) had the same genetic environments. The bla OXA-72 gene was flanked by conserved inverted repeats at the XerC/XerD binding sites [21] , indicating mobilization by site-specific recombination mechanisms. The rep1 gene was located downstream of bla OXA-72 (Accession no. AB857844).
Discussion
The relatively high MICs to piperacillin/tazobactam and carbapenems of the five P. rettgeri isolates were likely due to the presence of bla NDM-1 or bla OXA-72 . The enzymatic activities of metallo-β-lactamases, including NDM-1, were not inhibited by tazobactam [22] , a βlactamase inhibitor, in agreement with the MIC profiles of these isolates to piperacillin/tazobactam. The high MICs of all 5 isolates to ceftazidime, cefepime and aztreonam were likely due to the presence of bla VEB-1 [23] , and the presence of armA in these isolates was likely associated with their extremely high resistance to all aminoglycosides tested [11] . Point mutations in the quinolone-resistance-determining regions of gyrA and parC have been associated with high resistance to quinolones [24] . Point mutations in pmrCAB operon have been associated with the resistance of Acinetobacter spp. [25] and Pseudomonas aeruginosa [26] to polymxyin and colistin; and the presence of fos genes, including fosA, fosA2, fosA3, fosC and fosC2, has been associated with resistance to fosfomycin in Gram-negative bacteria [27] [28] [29] . Plasmids containing bla NDM-1 or bla OXA-72 may be disseminated among Gram-negative pathogens in Nepal. The genetic environments surrounding bla NDM-1 in our P. rettgeri strains (bla NDM-1 -ble MBL -trpF-dsbC-cutA1) were also observed in other plasmids, including A. baumannii plasmid pAbNDM-1 from China (Accession no. JN377410), Citrobacter freundii plasmid pYE315203 from China (Accession no. JX254913), E. coli plasmid pNDM102337 from Canada (Accession no. JF714412), K. pneumoniae plasmid pKP-NCGM18-1 from Nepal (Accession no. AB824738) [30] , K. pneumoniae plasmids pKPX-1, pKPN5047 and pNDM-HN380 from China (Accession nos. AP012055, KC311431 and JX104760, respectively), and P. rettgeri plasmid pFR90 (Accession no. JQ362415) from China. In addition, the genetic structures of OXA-72 producing Acinetobacter spp [31] [32] [33] [34] and K. pneumoniae (Accession no. JX268653 and AB825955 deposited in 2012 and 2013, respectively) had the same genetic structure (bla OXA-72 -rep1) as our strain of P. rettgeri.
Conclusions
To our knowledge, this is the first report describing P. rettgeri strains harboring bla NDM-1 or bla OXA-72 and armA isolated from patients in Nepal. These 5 strains were highly resistant to both β-lactams and aminoglycosides and expanded in a clonal manner in the hospital.
